| Budget Amount *help |
¥1,500,000 (Direct Cost: ¥1,500,000)
Fiscal Year 2001: ¥1,500,000 (Direct Cost: ¥1,500,000)
|
|---|
| Research Abstract |
The development of photochemical DNA cleaving agents, which selectively cleave DNA by irradiation with a specific light under mild conditions and without any additives such as metals and reducing agents, is very interesting from a chemical and biological standpoint and offers considerable potential in medicine especially in the post-genome era. Furthermore, photodynamic therapy using a photosensitizing drug has recently emerged as a promising modality against cancer and allied diseases. In this project, several artificial anthraquinone-carbohydrate, 2-phenylquinpline-carbohydrate, quinoxaline-carbohydrate, and β-carboline-carbohydrate hybrid molecules were designed and synthesized. Furthermore, it was found that they had light-induced DNA-cleaving activity with DNA base or sequence selectivity. In addition, the quinoxaline-carbohydrate hybrids completely kill HeLa S3 cells upon UV irradiation while no action occurs without light.
|
